|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.36 JOD | -1.45% |
|
0.00% | -4.90% |
Philadelphia Pharmaceuticals Company reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was JOD 1.95 million compared to JOD 1.87 million a year ago. Net income was JOD 0.170692 million compared to JOD 0.10561 million a year ago.
Basic earnings per share from continuing operations was JOD 0.023 compared to JOD 0.014 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.90% | 14.39M | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +19.22% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -8.33% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.22% | 5.52B |
PHILADELPHIA PHARMACEUTICALS COMPANY 
